Drug
Suspensions clinical trials
- studies test it
- 5
- open now
- 0
- in phase 3
- 0
- first study started
- 2008
How studies write it
Studies that test it under each name
Combined with it in one product
Studies by the year they started
5 studies that test it; most in 2008 (1)
| Year | Studies |
|---|---|
| 2008 | 1 |
| 2009 | 1 |
| 2012 | 1 |
| 2014 | 1 |
| 2016 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 5
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 5 · Other 0
Often tested with
Tested in the same studies.
Finerenone (1) · PF-06700841 (1) · JNJ-47910382 (1) · Tablets (1)
Studies
Open first, then newest update. How each study uses Suspensions is read from its arms, and is right about nine times in ten.
Testing it · 5
- A Four-Way Cross-Over Study To Compare The Plasma Concentrations Of PF-02413873 After Oral Administration Of Several Doses As Suspension And As Tablets.TerminatedPhase 1PfizerNCT00857571Written as 150 mg Suspension
- Study of Finerenone to Investigate a Paediatric Formulation in Healthy Male SubjectsCompletedPhase 1BayerNCT02957396Written as Finerenone (BAY94-8862): 20 mg suspension
- A Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Study Of PF-06700841, With Bioavailability/Food Effect InvestigationCompletedPhase 1PfizerNCT02310750Written as PF-06700841 oral solution/suspension
- A Study to Compare the Bioavailability of JNJ-47910382 Formulated as a Tablet and as Suspension in Healthy ParticipantsCompletedPhase 1Janssen R&D IrelandNCT01662661Written as JNJ-47910382 (suspension)
- Study of Controlled Release Formulations of CE-224,535 Against the Immediate Release Formulation in Normal VolunteersCompletedPhase 1PfizerNCT00782600Written as suspension IR